Literature DB >> 122663

The influence of drug therapy on serum immunoglobulin profiles in rheumatoid arthritis.

A J Swannell1, J Watkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 122663      PMCID: PMC1543572     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  5 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis.

Authors:  M Farr; M J Kendall; D W Young; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

3.  Serum levels of IgG, IgM, and IgA in rheumatoid arthritis.

Authors:  E M Veys; H E Claessens
Journal:  Ann Rheum Dis       Date:  1968-09       Impact factor: 19.103

4.  Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

Authors:  R Bluestone; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

5.  Penicillamine in rheumatoid arthritis.

Authors:  J Zuckner; R H Ramsey; R W Dorner; G E Gantner
Journal:  Arthritis Rheum       Date:  1970 Mar-Apr
  5 in total
  2 in total

1.  The influence of D-penicillamine therapy on numbers of circulating immunoglobulin secreting cells in rheumatoid arthritis.

Authors:  V Gul; C F Corke; E C Huskisson; E J Holborow
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

2.  Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  J S Dixon; M E Pickup; J R Lowe; C Hallett; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.